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Background
During acute HIV infection (AHI), CD4+ T cells undergo
apoptosis from direct infection and through bystander
apoptosis induced by inflammatory factors. Both the
inflammatory factors and apoptotic material produced
during AHI may negatively impact innate and adaptive
immune responses. Such inhibitory factors present in AHI
plasma include apoptotic microparticles (MPs), small
membranous blebs derived from dying cells. Dendritic
cells (DCs) are the sentinel cells of the immune system
that respond to pathogens, frequently through Toll-like
receptor (TLR) recognition of unique pathogenic macro-
molecules. Because TLR recognition of viral material by
DCs is important for DC priming of virus-specific T cells,
we determined how AHI patient plasma or apoptotic MPs
affect TLR-stimulated DCs.
Methods
Plasma was obtained from acute HIV patients or healthy
donor controls. Apoptotic MPs were isolated from super-
natant of UV-irradiated or HIV-infected PBMCs. Human
DCs were treated with MPs or 10% plasma (control or
AHI) and subsequently stimulated with various TLR ago-
nists. DC activation was then assessed by examining DC
phenotype, cytokine production, and ability to activate
naïve allogeneic or autologous memory CD4+ T cells. MP-
specific receptors were isolated from the DC surface and
sequenced by mass spectrometry.
Results
AHI plasma, relative to healthy plasma, inhibited TLR-
stimulated DC cytokine production. Because apoptotic
MPs are present at high levels in AHI plasma, we treated
DCs with MPs and observed reduced DC activation. The
inhibition of DCs by AHI or MPs blocked DC capacity to
induce IFNgamma-producing T helper 1 CD4+ T cells,
which are critical regulators of cell-mediated immunity.
MP-specific DC receptors include various integrins, CD97,
HLA class I, and voltage-dependent anionic channels
(VDAC).
Conclusion
Determining the factors in AHI, such as apoptotic MPs,
which block DC function will provide potential targets to
stimulate HIV-specific immunity. We are currently inves-
tigating molecular mechanisms of AHI and MP-mediated
DC inhibition.
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